✦ LIBER ✦

P1-026 Consistent long-term efficacy of rivastigmine in mild, moderate and moderately severe Alzheimer's disease

✍ Scribed by Daniel Kaufer; Peter Quang; Rene Spiegel

Book ID: 117412907
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 147 KB
Volume: 25
Category: Article
ISSN: 0197-4580
DOI: 10.1016/s0197-4580(04)80340-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of rivastigmine in subjects wit

Efficacy of rivastigmine in subjects with moderately severe Alzheimer's disease

✍ A. Burns; R. Spiegel; P. Quarg 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

## Abstract ## Background Cholinesterase (ChE) inhibitors are primarily used in the treatment of mild to moderate Alzheimer's disease (AD), but may also be effective in more severe disease. ## Objective To evaluate the dual ChE inhibitor, rivastigmine, in more severe dementia. ## Methods We re

Long-term effects of rivastigmine in mod

Long-term effects of rivastigmine in moderately severe Alzheimer's disease: Does early initiation of therapy offer sustained benefits?

✍ P.Murali Doraiswamy; K.Ranga Rama Krishnan; Ravi Anand; Hyesung Sohn; Jacquiline 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Long-term efficacy and safety of galanta

Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer's disease: multicenter trial

✍ T. Pirttilä; G. Wilcock; L. Truyen; C. V. Damaraju 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB

P102 A long-term study on the safety of

P102 A long-term study on the safety of rivastigmine capsule and patch in mild to moderate Parkinson’s disease dementia

✍ A. Storch; P. Barone; P. De Deyn; M. Emre; J. Kulisevsky; W. Poewe; E. Pourcher; 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 47 KB

Impact of Alzheimer's disease and rivast

Impact of Alzheimer's disease and rivastigmine treatment on activities of daily living over the course of mild to moderately severe disease

✍ Steven G Potkin; Ravi Anand; Richard Hartman; Jeffrey Veach; George Grossberg 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 109 KB

A long-term, double-blind, placebo-contr

A long-term, double-blind, placebo-controlled efficacy and safety study of nicergoline in patients with mild to moderate Alzheimer's disease

✍ L. Amaducci; K. Maurer; B. Winblad; R. Dom; R. Bullock; L. Bonura; A. Battaglia; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 291 KB